Marketed Therapies
Below is a list of our company's marketed products. This information is intended only for residents of Australia.
AVONEX® (interferon beta-1a)
Registered in Australia in October 1999.
For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)
FAMPYRA® (fampridine)
Registered in Australia in May 2011.
For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)
PLEGRIDY™ (peginterferon beta-1a)
Registered in Australia in November 2014.
For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)
SPINRAZA™ (nusinersen)
Registered in Australia in November 2017.
For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)
TECFIDERA® (dimethyl fumarate)
Registered in Australia in July 2013.
For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)
TYSABRI® (natalizumab)
Registered in Australia in November 2006.
For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)